Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Rosenkilde

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|February 29, 2000
Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptorM M Rosenkilde, T W Schwartz
Trends in Pharmacological Sciences|June 1, 1996
Is there a 'lock' for all agonist 'keys' in 7TM receptors?T W Schwartz, M M Rosenkilde
British Journal of Pharmacology|February 13, 2010
Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variantsT Benned-Jensen, M M Rosenkilde
Current Molecular Pharmacology|December 22, 2009
The role of transmembrane segment II in 7TM receptor activationT Benned-Jensen, M M Rosenkilde
Mini Reviews in Medicinal Chemistry|January 22, 2010
Targeting CXCR4 in HIV cell-entry inhibitionA Steen, T W Schwartz, M M Rosenkilde
British Journal of Pharmacology|January 22, 2008
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptorsM M Rosenkilde, M J Smit, M Waldhoer
FEBS Letters|January 12, 1999
Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28T N Kledal, M M Rosenkilde, T W Schwartz
FEBS Letters|December 16, 1998
Natural agonist enhancing bis-His zinc-site in transmembrane segment V of the tachykinin NK3 receptorM M Rosenkilde, M Lucibello, B Holst, et al.
Oncogene|April 21, 2001
Virally encoded 7TM receptorsM M Rosenkilde, M Waldhoer, H R Lüttichau, et al.
British Journal of Pharmacology|July 22, 2014
Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesisS Thiele, J Mungalpara, A Steen, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|February 29, 2000
Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptorM M Rosenkilde, T W Schwartz
Trends in Pharmacological Sciences|June 1, 1996
Is there a 'lock' for all agonist 'keys' in 7TM receptors?T W Schwartz, M M Rosenkilde
British Journal of Pharmacology|February 13, 2010
Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variantsT Benned-Jensen, M M Rosenkilde
Current Molecular Pharmacology|December 22, 2009
The role of transmembrane segment II in 7TM receptor activationT Benned-Jensen, M M Rosenkilde
Mini Reviews in Medicinal Chemistry|January 22, 2010
Targeting CXCR4 in HIV cell-entry inhibitionA Steen, T W Schwartz, M M Rosenkilde
British Journal of Pharmacology|January 22, 2008
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptorsM M Rosenkilde, M J Smit, M Waldhoer
FEBS Letters|January 12, 1999
Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28T N Kledal, M M Rosenkilde, T W Schwartz
FEBS Letters|December 16, 1998
Natural agonist enhancing bis-His zinc-site in transmembrane segment V of the tachykinin NK3 receptorM M Rosenkilde, M Lucibello, B Holst, et al.
Oncogene|April 21, 2001
Virally encoded 7TM receptorsM M Rosenkilde, M Waldhoer, H R Lüttichau, et al.
British Journal of Pharmacology|July 22, 2014
Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesisS Thiele, J Mungalpara, A Steen, et al.
Pageof 4